HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Robert D. Dowling Laman A. Gray, Jr Steven W. Etoch Hillel Laks Daniel Marelli Louis Samuels John Entwistle Gus J. Vlahakes Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dowling, R. D. Articles by Frazier, O. H. Search for Related Content PubMed PubMed Citation Articles by Dowling, R. D. Articles by Frazier, O. H. Related Collections Mechanical Circulatory Assistance

J Thorac Cardiovasc Surg 2004;127:131-141
© 2004 The American Association for Thoracic Surgery

Surgery for acquired cardiovascular disease

Initial experience with the AbioCor Implantable Replacement Heart System

^a Department of Surgery, Division of Thoracic and Cardiovascular Surgery, University of Louisville School of Medicine, Louisville, Ky, USA
^b Division of Cardiothoracic Surgery, University of California Los Angeles School of Medicine, Los Angeles, Calif, USA
^c Division of Cardiothoracic Surgery, MCP Hahnemann University, Philadelphia, Pa, USA
^d Division of Cardiothoracic Surgery, Texas Heart Institute Medical Center, Houston, Tex, USA
^e Division of Cardiac Surgery, Massachusetts General/Brigham & Women's Hospital, Boston, Mass, USA

Received for publication May 14, 2002; revisions received July 25, 2003; accepted for publication July 30, 2003.

^* Address for reprints: Robert D. Dowling, MD, 201 Abraham Flexner Way, #1200, Louisville, KY 40202, USA
rdowling{at}ucsamd.com
jwalsh{at}ucsamd.com

OBJECTIVE: We sought to evaluate the safety and efficacy of the first available totally implantable replacement heart (AbioCor Implantable Replacement Heart System) in the treatment of severe, irreversible biventricular heart failure in human patients.

METHODS: Seven male adult patients with severe, irreversible biventricular failure (>70% thirty-day predicted mortality) who were not candidates for transplantation met all institutional review board study criteria and had placement of the AbioCor Implantable Replacement Heart. All were in cardiogenic shock despite maximal medical therapy, including inotropes and intra-aortic balloon pumps. Mean age was 66.7 ± 10.4 years (range, 51-79 years). Four of 7 patients had prior operations. Six had ischemic and one had idiopathic cardiomyopathy. All had 3-dimensional computer-simulated implantation of the thoracic unit that predicted adequate fit. At the time of the operation, the internal transcutaneous energy transfer coil, battery, and controller were placed. Biventriculectomy was then performed, and the thoracic unit was placed in an orthotopic position and attached to the atrial cuffs and outflow conduits with quick-connects. The flow was adjusted to 4 to 8 L/min. Central venous and left atrial pressures were maintained at 5 to 15 mm Hg. The device is powered through transcutaneous energy transfer. An atrial flow-balancing chamber is used to adjust left/right balance. The balance chamber and transcutaneous energy transfer eliminate the need for percutaneous lines.

RESULTS: There was one intraoperative death caused by coagulopathic bleeding and one early death caused by an aprotinin reaction. There have been multiple morbidities primarily related to preexisting illness severity: 5 patients had prolonged intubation, 2 had hepatic failure (resolved in 1), 4 had renal failure (resolved in 3), and 1 each had recurrent gastrointestinal bleeding, acute cholecystitis requiring laparotomy, respiratory failure that resolved after 3 days of extracorporeal membrane oxygenation, and malignant hyperthermia (resolved). There were 3 late deaths: one caused by multiple systems organ failure (postoperative day 56), one caused by a cerebrovascular accident (postoperative day 142), and one caused by retroperitoneal bleeding and resultant multiple systems organ failure (postoperative day 151). This latter patient was not able to tolerate anticoagulation (no anticoagulation or antiplatelet therapy alone for 80% of the first 60 days) and had a transient ischemic attack on postoperative day 61 and a cerebrovascular accident on postoperative day 130. At autopsy, blood pumps were clean. The 2 patients who had large cerebrovascular accidents had thrombus on the atrial cage struts. These struts have been removed for future implants. There has been no significant hemolysis or device-related infections. The balance chamber has allowed for left/right balance in all patients (left atrial pressure within 5 mm Hg of right atrial pressure). Three patients have taken multiple (>50) trips out of the hospital, and 2 have been discharged from the hospital. Total days on support with the AbioCor are 759.

CONCLUSION: The initial clinical experience suggests that the AbioCor might be effective therapy in patients with advanced biventricular failure. There have been no significant device malfunctions. Two of these patients have been discharged from the hospital.

This article has been cited by other articles:

				M. J. Russo, K. N. Hong, R. R. Davies, J. M. Chen, R. A. Sorabella, D. D. Ascheim, M. R. Williams, A. C. Gelijns, A. S. Stewart, M. Argenziano, et al. Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices. J. Thorac. Cardiovasc. Surg., December 1, 2009; 138(6): 1425 - 1432.e3. [Abstract] [Full Text] [PDF]

				F. Nicolini and T. Gherli Alternatives to transplantation in the surgical therapy for heart failure Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 214 - 228. [Abstract] [Full Text] [PDF]

				S. Aggarwal, F. Cheema, M. C. Oz, and Y. Naka Long-Term Mechanical Circulatory Support Card. Surg. Adult, January 1, 2008; 3(2008): 1609 - 1628. [Full Text]

				A. S. Bryant, W. L. Holman, N. C. Nanda, S. Vengala, M. S. Blood, S. V. Pamboukian, and J. K. Kirklin Native Aortic Valve Insufficiency in Patients With Left Ventricular Assist Devices Ann. Thorac. Surg., February 1, 2006; 81(2): e6 - e8. [Abstract] [Full Text] [PDF]

				S. Schenk, P. M. McCarthy, E. H. Blackstone, J. Feng, R. C. Starling, J. L. Navia, L. Zhou, K. J. Hoercher, N. G. Smedira, and K. Fukamachi Duration of inotropic support after left ventricular assist device implantation: Risk factors and impact on outcome J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 447 - 454. [Abstract] [Full Text] [PDF]

				D. Mancini and D. Burkhoff Mechanical Device-Based Methods of Managing and Treating Heart Failure Circulation, July 19, 2005; 112(3): 438 - 448. [Abstract] [Full Text] [PDF]